Erlotinib for Hepatocellular Carcinoma Chemoprevention

Clinical trial NCT04172779 · NOT_YET_RECRUITING

Trial details

NCT number: NCT04172779
Sponsor: University of Texas Southwestern Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cirrhosis, Liver Advanced Liver Fibrosis

Start date: 2026-12-01
Primary completion: 2030-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.